Literature DB >> 16632006

Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation.

Marije R Vergeer1, Patricia Doornaert, C René Leemans, Jan Buter, Ben J Slotman, Johannes A Langendijk.   

Abstract

BACKGROUND AND
PURPOSE: In the present study, prognostic values of several CT-based pre-treatment nodal and treatment-related characteristics were evaluated among patients with squamous cell head and neck cancer treated with non-surgical modalities. PATIENTS AND METHODS: Included were 79 patients with 210 pathological nodes, who underwent primary irradiation or chemoradiation. Several nodal characteristics were assessed on the planning CT scan. In addition, the 3D-dose distribution in the nodes was calculated by the planning system to allow for evaluation of underdosage in the pathological nodes and to correlate these results with control in the neck. Analysis was done on patient level (regional control) and node level (nodal control).
RESULTS: For regional control, total nodal volume and the use of chemotherapy in addition to radiation were significant prognostic factors. For nodal control, also the presence of central necrosis and radiological extranodal spread were of importance. In case of radiotherapy alone, a minimal dose <95% of the prescribed dose was associated with worse control. In case of combined modality treatment, the minimal radiation dose was of less importance.
CONCLUSIONS: Nodal volume and chemotherapy are the most important prognostic factors to control pathological nodes in the neck. Radiological central necrosis and extranodal growth, nodal volume and chemotherapy were significant prognostic factors for nodal control. Additionally, it appears that regional control in patients treated with primary radiation alone or with chemoradiation in case of a total nodal volume of more than 3.0 cm(3) results in an unacceptable high risk on regional recurrence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632006     DOI: 10.1016/j.radonc.2006.03.008

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  Up-front neck dissection followed by concurrent chemoradiation in patients with regionally advanced head and neck cancer.

Authors:  Peter A Paximadis; Michael E Christensen; Greg Dyson; Dev P Kamdar; Ammar Sukari; Ho-Sheng Lin; George H Yoo; Harold E Kim
Journal:  Head Neck       Date:  2012-02-06       Impact factor: 3.147

2.  Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma.

Authors:  Juliette Thariat; K Kian Ang; Pamela K Allen; Anesa Ahamad; Michelle D Williams; Jeffrey N Myers; Adel K El-Naggar; Lawrence E Ginsberg; David I Rosenthal; Bonnie S Glisson; William H Morrison; Randal S Weber; Adam S Garden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-01       Impact factor: 7.038

3.  Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.

Authors:  S Chawla; S Kim; L A Loevner; W-T Hwang; G Weinstein; A Chalian; H Quon; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-24       Impact factor: 3.825

4.  The impact of treatment center on the outcome of patients with laryngeal cancer treated with surgery and radiotherapy.

Authors:  Fadime Can Akman; Nihal Dag; Ozlem Uruk Ataman; Cenk Ecevit; Ahmet Omer Ikiz; Isin Arslan; Sulen Sarioglu; Emel Ada; Munir Kinay
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-04-05       Impact factor: 2.503

5.  Treatment of T3 laryngeal cancer in the Netherlands: a national survey.

Authors:  Patricia Doornaert; Chris H J Terhaard; Johannes H Kaanders
Journal:  Radiat Oncol       Date:  2015-06-26       Impact factor: 3.481

6.  Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns.

Authors:  Yu-Han Huang; Chih-Hua Yeh; Nai-Ming Cheng; Chien-Yu Lin; Hung-Ming Wang; Sheung-Fat Ko; Cheng-Hong Toh; Tzu-Chen Yen; Chun-Ta Liao; Shu-Hang Ng
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.